Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C P Denton

Showing results (41-50 of 98) with videos related to

Pageof 10
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV|August 9, 2011
Biomarkers for skin involvement and fibrotic activity in sclerodermaP Moinzadeh, C P Denton, D Abraham, et al.
Clinical and Experimental Dermatology|November 18, 2003
Etanercept-induced systemic lupus erythematosusV J Swale, C M Perrett, C P Denton, et al.
Clinical and Experimental Rheumatology|September 19, 2008
Inhaled iloprost for the treatment of Raynaud's phenomenonA Pakozdi, K Howell, H Wilson, et al.
QJM : Monthly Journal of the Association of Physicians|May 23, 2013
Targeting the endothelin axis in scleroderma renal crisis: rationale and feasibilityH Penn, N Quillinan, K Khan, et al.
Journal of Cardiovascular Pharmacology|May 22, 1998
Endothelins: effect on matrix biosynthesis and proliferation in normal and scleroderma fibroblastsS Xu, C P Denton, A Holmes, et al.
Arthritis and Rheumatism|January 1, 2000
Losartan therapy for Raynaud's phenomenon and scleroderma: clinical and biochemical findings in a fifteen-week, randomized, parallel-group, controlled trialM Dziadzio, C P Denton, R Smith, et al.
Rheumatology (Oxford, England)|May 6, 2003
A cross-sectional comparison of three self-reported functional indices in sclerodermaA E Smyth, A J MacGregor, D Mukerjee, et al.
Clinical and Experimental Immunology|November 20, 1998
Scleroderma fibroblasts promote migration of mononuclear leucocytes across endothelial cell monolayersC P Denton, X Shi-Wen, A Sutton, et al.
Rheumatology (Oxford, England)|April 20, 2001
Pulmonary hypertension in systemic sclerosis: risk factors for progression and consequences for survivalA J MacGregor, R Canavan, C Knight, et al.
British Journal of Rheumatology|February 1, 1997
Comparison of Doppler echocardiography and right heart catheterization to assess pulmonary hypertension in systemic sclerosisC P Denton, J B Cailes, G D Phillips, et al.
Pageof 10

Showing results (41-50 of 98) with videos related to

Sort By:
Pageof 10
Journal of the European Academy of Dermatology and Venereology : JEADV|August 9, 2011
Biomarkers for skin involvement and fibrotic activity in sclerodermaP Moinzadeh, C P Denton, D Abraham, et al.
Clinical and Experimental Dermatology|November 18, 2003
Etanercept-induced systemic lupus erythematosusV J Swale, C M Perrett, C P Denton, et al.
Clinical and Experimental Rheumatology|September 19, 2008
Inhaled iloprost for the treatment of Raynaud's phenomenonA Pakozdi, K Howell, H Wilson, et al.
QJM : Monthly Journal of the Association of Physicians|May 23, 2013
Targeting the endothelin axis in scleroderma renal crisis: rationale and feasibilityH Penn, N Quillinan, K Khan, et al.
Journal of Cardiovascular Pharmacology|May 22, 1998
Endothelins: effect on matrix biosynthesis and proliferation in normal and scleroderma fibroblastsS Xu, C P Denton, A Holmes, et al.
Arthritis and Rheumatism|January 1, 2000
Losartan therapy for Raynaud's phenomenon and scleroderma: clinical and biochemical findings in a fifteen-week, randomized, parallel-group, controlled trialM Dziadzio, C P Denton, R Smith, et al.
Rheumatology (Oxford, England)|May 6, 2003
A cross-sectional comparison of three self-reported functional indices in sclerodermaA E Smyth, A J MacGregor, D Mukerjee, et al.
Clinical and Experimental Immunology|November 20, 1998
Scleroderma fibroblasts promote migration of mononuclear leucocytes across endothelial cell monolayersC P Denton, X Shi-Wen, A Sutton, et al.
Rheumatology (Oxford, England)|April 20, 2001
Pulmonary hypertension in systemic sclerosis: risk factors for progression and consequences for survivalA J MacGregor, R Canavan, C Knight, et al.
British Journal of Rheumatology|February 1, 1997
Comparison of Doppler echocardiography and right heart catheterization to assess pulmonary hypertension in systemic sclerosisC P Denton, J B Cailes, G D Phillips, et al.
Pageof 10